Amicus Therapeutics, Inc. (FOLD) CEO John Crowley on Q4 2018 Results - Earnings Call Transcript [Seeking Alpha]
Amicus Therapeutics, Inc. (FOLD)
Last amicus therapeutics, inc. earnings: 11/11 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.amicusrx.com/investor-relations
Company Research
Source: Seeking Alpha
Amicus Therapeutics, Inc. (FOLD) CEO John Crowley on Q4 2018 Results - Earnings Call Transcript Amicus Therapeutics, Inc. (NASDAQ: FOLD Company Participants Sara Pellegrino - Vice President of Investor Relations and Corporate Communication John Crowley - Chairman and Chief Executive Officer Bradley Campbell - President and Chief Operating Officer Daphne Quimi - Chief Financial Officer Jay Barth - Chief Medical Officer Jeff Castelli - Chief Officer and Head of Gene Therapy Conference Call Participants Anupam Rama - JPMorgan Tazeen Ahmad - Bank of America Irina Margine - Cowen and Company Michael Ulz - Robert W. Baird & Co. Mohit Bansal - Citigroup Whitney Ijem - Guggenheim Securities Kristen Kluska - Cantor Fitzgerald Operator Good day, ladies and gentlemen, and welcome to Amicus Therapeutics Full-year 2018 Financial Results and Corporate Update Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session. Instructions
Show less
Read more
Impact Snapshot
Event Time:
FOLD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
FOLD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
FOLD alerts
High impacting Amicus Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
FOLD
News
- Amicus Therapeutics, Inc. (NASDAQ: FOLD) had its "hold" rating re-affirmed by analysts at Needham & Company LLC.MarketBeat
- Amicus Therapeutics, Inc. (NASDAQ: FOLD) had its price target lowered by analysts at Bank of America Co. from $14.00 to $13.00. They now have a "buy" rating on the stock.MarketBeat
- Amicus Therapeutics (FOLD) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates [Yahoo! Finance]Yahoo! Finance
- Amicus Therapeutics Announces First Quarter 2024 Financial Results and Corporate UpdatesGlobeNewswire
- Amicus Therapeutics to Present at the Bank of America 2024 Health Care ConferenceGlobeNewswire
FOLD
Earnings
- 5/9/24 - Miss
FOLD
Sec Filings
- 5/9/24 - Form 10-Q
- 5/9/24 - Form 8-K
- 5/3/24 - Form 4
- FOLD's page on the SEC website